Observational, Non-Interventional Study Supporting Validation of VO2Max Estimation Methods Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET)

NCT ID: NCT05678530

Last Updated: 2025-12-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-06-06

Study Completion Date

2027-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the hypothesis being explored is that VO2Max and other CPET parameters can be accurately estimated from biosignals (namely, motion from accelerometers and cardiopulmonary variables from EKG) collected during activities of daily living using wearable biosensors worn by study participants. This study will aim to collect development and validation data for a machine learning algorithm and to evaluate the performance of the algorithm. A total of 1000 participants will be enrolled including: (Normal) 100 participants, self-reported healthy male and female participants aged 18 to 80 and (Standard of Care) 900 participants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiopulmonary

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy

Healthy Subjects who undergo the CPET

No interventions assigned to this group

Standard of Care

Standard of Care subjects who undergo the CPET as part of routine Standard of Care

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Willing and able to comply with protocol procedures and available for the duration of the study.
2. Willing to sign and date informed consent document for study participation.
3. Participant is undergoing the Cardiopulmonary Exercise Test (CPET) as Standard of Care

Exclusion Criteria

1. Participant is pregnant, lactating or ≤30 days post-partum.
2. Participant has limited or no intrinsic sinus node function (i.e. chronic atrial pacing).

• If participant has an indwelling cardiac device and programming cannot be sufficiently ascertained to assure sinus node competence and lack of atrial pacing, the patient should be excluded.
3. Barostim (™) or similar noncardiac electrical pulse generating device in situ.
4. Complex congenital heart disease (even repaired or palliated) with the following exception:

• Biventricular physiology without severe valvar dysfunction (e.g. free pulmonary insufficiency) at the discretion of the investigator.
5. Any history of allergy to adhesive
6. Any cognitive or physical limitations that, in the opinion of the investigator, limits the participant's ability to fully follow study procedures and/or reach a respiratory exchange ratio of 1.0.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Prolaio

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Greg Kurio, MD

Role: STUDY_DIRECTOR

Prolaio, Inc

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mayo Clinic Arizona

Scottsdale, Arizona, United States

Site Status RECRUITING

VA Palo Alto Healthcare System

Palo Alto, California, United States

Site Status RECRUITING

University of California San Francisco

San Francisco, California, United States

Site Status RECRUITING

The Lundquist Institute

Torrance, California, United States

Site Status RECRUITING

Nemours Cardiac Center

Wilmington, Delaware, United States

Site Status RECRUITING

Memorial Healthcare System, Office of Human Research

Hollywood, Florida, United States

Site Status RECRUITING

Mayo Clinic Florida

Jacksonville, Florida, United States

Site Status RECRUITING

New Generation of Medical Research

Naples, Florida, United States

Site Status RECRUITING

physIQ

Chicago, Illinois, United States

Site Status COMPLETED

University of Illinois Hospital & Health Sciences System

Chicago, Illinois, United States

Site Status RECRUITING

Advocate Aurora Health Institute

Oakbrook Terrace, Illinois, United States

Site Status COMPLETED

Mayo Clinic

Rochester, Minnesota, United States

Site Status RECRUITING

Baylor Scott & White Research Institute

Dallas, Texas, United States

Site Status RECRUITING

Baylor Scott & White The Heart Hospital - Plano

Plano, Texas, United States

Site Status RECRUITING

Intermountain Medical Center

Murray, Utah, United States

Site Status RECRUITING

Eastern Health Cardiac Rehabilitation

St. John's, Newfoundland and Labrador, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Clinical Trials at Prolaio

Role: CONTACT

Phone: 855-869-9054

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Research Technologist

Role: primary

Clinical Research Coordinator

Role: primary

Clinical Research Coordinator

Role: primary

Clinical Trial Project Manager

Role: primary

Research Coordinator

Role: backup

Research Program Manager

Role: primary

Clinical Research Coordinator

Role: primary

Clinical Research Coordinator

Role: primary

Clinical Research Coordinator

Role: primary

Dr. Cemal Ozemek

Role: primary

Research Technologist

Role: primary

Research Enrollment Analyst

Role: primary

Supervisor Clinical Research

Role: primary

Project Coordinator, Outpatient Pulmonary Research

Role: primary

Clinical Research Coordinator

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CTP-020

Identifier Type: -

Identifier Source: org_study_id